Castleark Management LLC Madrigal Pharmaceuticals, Inc. Transaction History

Castleark Management LLC

  • $2.41 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$193.33 - $291.99 $15,466 - $23,359
-80 Reduced 0.87%
9,130 $2.56 Million
Q1 2024

May 15, 2024
BUY
$171.37 - $283.23 $1.58 Million - $2.61 Million
9,210 New
9,210 $2.46 Million
Q2 2023

Aug 15, 2023
BUY
$203.88 - $312.0 $1.95 Million - $2.98 Million
9,560 New
9,560 $2.21 Million

Others Institutions Holding MDGL

# of Institutions
298
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.76B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email